Effect of Modified Cellulose on Colonic Fermentation of Inulin (COCOA2)
Irritable Bowel Syndrome
About this trial
This is an interventional basic science trial for Irritable Bowel Syndrome focused on measuring FODMAP (fermentable oligo-mono-di-saccharides and polyhydric alcohols, Inulin, Psyllium, Cellulose
Eligibility Criteria
Inclusion Criteria: Aged 18 or older. Able to give informed consent. Scoring ≤5 (i.e., mild, or less) for symptoms of flatulence, bloating, abdominal pain, loose stool, and hard stool in previous 2 weeks using a modified Gastrointestinal Symptom Rating Scale (5). Agrees to consume the meals provided. Agrees to not smoke during the breath sampling period. Exclusion Criteria: Pregnancy declared by candidate. History declared by the candidate of pre-existing gastrointestinal disorder that may affect bowel function. Reported history of previous resection of the oesophagus, stomach, or intestine (excluding appendix). Intestinal stoma. Any medical condition making participation potentially compromising participation in the study e.g., diabetes mellitus, respiratory disease limiting ability to use breath hydrogen analyser, known intolerance to one of the test substances. Will not agree to dietary restrictions required. Unable to stop drugs known to alter GI motility including mebeverine, opiates, monoamine oxidase inhibitors, phenothiazines, benzodiazepines, calcium channel antagonists for the duration of the study (Selective serotonin reuptake inhibitors, low dose tricyclic antidepressants, antihistamines, and oral contraceptive pill will be recorded in the CRF but will not be an exclusion criteria). Participants who are taking antibiotics or probiotics as it might alters gut microbiota. Poor understanding of English language. Participation in night shift work the week prior to the study day. Night work is defined as working between midnight and 6.00 AM. Anyone who in the opinion of the investigator is unlikely to be able to comply with the protocol e.g., cognitive dysfunction, chaotic lifestyle related to substance abuse. Having taken part in a research study in the last 3 months involving invasive procedures or an inconvenience allowance.
Sites / Locations
- University Hospital Clinical Research CentreRecruiting
Arms of the Study
Arm 1
Arm 2
Arm 3
Active Comparator
Placebo Comparator
Experimental
Psyllium
maltodextrin
Methylcellulose
Psyllium 15 g+ inulin 15 gm in 375ml water
Maltodextrin 15 g + inulin 15 gm in 375 ml water
Methylcellulose 15g + Inulin 15 g in 375 ml water